Rate this post

Ro.co vs Peter MD: Compare GLP-1 Programs & Pricing

Side-by-side Ro.co and Peter MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Ro.co and Peter MD are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Ro.co vs Peter MD to help you identify which platform aligns best with your health goals, budget, and preferred level of clinical support.

Visit Ro.co
Explore Peter MD

Ro.co vs Peter MD: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Ro.co			Brand med access	$145.00 — Yes
Peter MD				—

Ro.co vs Peter MD: Medical Process & Accessibility

Both providers operate entirely online, meaning you can start the intake process from a smartphone or computer. Ro.co emphasizes a rapid, questionnaire‑driven intake followed by a tele‑visit with a licensed clinician who can approve a prescription within 24‑48 hours. Peter MD uses a similar digital questionnaire but adds a scheduled video consult and a structured follow‑up schedule to fine‑tune dosing over the first 12 weeks. All prescriptions are filled by U.S. pharmacies that compound GLP‑1 medications under FDA‑registered protocols.

Start with Ro.co

Ro.co vs Peter MD: Pricing Comparison

Ro.co lists a membership fee of $145.00, which covers the clinical oversight, telehealth visits, and the compounding service fee. The actual drug cost is added on a per‑prescription basis; however, Ro.co currently advertises a “Brand med access” promotional offering that may reduce the first‑month medication price. Peter MD does not publish a flat membership fee, instead charging a per‑visit fee that varies with the chosen dosage tier. Because neither provider discloses a fixed drug‑price for semaglutide or tirzepatide in the public domain, the table above leaves those cells blank.

When evaluating total cost, consider both the membership/visit fee and the per‑dose price. If you already have insurance that covers GLP‑1 therapy, the membership fee may be the primary out‑of‑pocket expense. If you are paying out‑of‑pocket, the per‑dose price (often ranging from $300‑$500 per month for compounded semaglutide) will dominate the budget.

Compare Peter MD Pricing

Ro.co vs Peter MD: Clinical Oversight & Support

Both platforms provide direct access to board‑certified physicians, nurse practitioners, or physician assistants who specialize in obesity medicine. Ro.co typically offers a single telehealth visit for prescription approval followed by asynchronous messaging for routine questions. Peter MD incorporates scheduled check‑ins at weeks 4, 8, and 12, allowing clinicians to adjust dose increments based on weight loss, side‑effects, and patient tolerance.

Book a Consultation with Ro.co

Ro.co vs Peter MD: Medication Quality & Safety

Each provider dispenses compounded GLP‑1 products from FDA‑registered compounding pharmacies. These formulations are chemically identical to the branded versions (e.g., Wegovy® for semaglutide, Mounjaro® for tirzepatide) but are typically offered at a lower price point because they are not branded. All compounding pharmacies must follow strict USP ^{Chapter 795} guidelines, ensuring potency, sterility, and accurate dosing.

Ro.co vs Peter MD: Customer Experience

Online reviews highlight that Ro.co users appreciate the straightforward onboarding, quick prescription turnaround, and transparent membership fee. Some patients note that the lack of scheduled follow‑ups can feel impersonal if side‑effects arise. In contrast, Peter MD receives praise for its proactive clinician outreach, detailed educational resources, and a clear step‑by‑step dose‑escalation plan. Both companies report average shipping times of 5‑7 business days after prescription approval.

Explore Peter MD Reviews

Ro.co vs Peter MD: Final Verdict

If you prioritize a low‑cost entry point, a single membership fee, and rapid prescription fulfillment, Ro.co may be the better fit. If you prefer a more hands‑on clinical journey with scheduled dose‑adjustment visits and a higher level of ongoing support, Peter MD could be the right choice. Both platforms operate under U.S. telehealth regulations, employ licensed clinicians, and adhere to FDA‑compliant compounding standards, making them safe options for patients seeking GLP‑1 therapy.

Join Ro.co
Get Started with Peter MD

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice